Investment Banking

Founded in 1952, Tapemark’s first service offering was printing on self-wound tape. As an early leader in pressure-sensitive adhesives, their expertise evolved to include single-use medical and personal care products. Today, Tapemark specializes in the development and manufacturing of multiple drug delivery systems delivering both Rx and OTC pharmaceuticals via transdermal patches, oral films, and unit dose topical applicators.

SECTOR: Pharmaceuticals
YEAR: August 2022
DEAL SIZE: Undisclosed
MANDATE TYPE: Sell-Side M&A Advisory

Oakrum Pharma, LLC is a privately-owned biopharmaceutical company focusing on development and commercialization of affordable drug therapies, located in St. Louis, Missouri. Through a business model of collaborating with experts in various disciplines and leveraging a global network of business partners, Oakrum Pharma intends to provide more options to small, specialty and rare disease markets.

SECTOR: Pharmaceuticals
YEAR: July 2022
DEAL SIZE: Undisclosed
MANDATE TYPE: Sell-Side M&A Advisory

Fagron is a global, vertically integrated pharmaceutical company delivering personalized medical solutions safely to over 300,000 patient-focused customers. Fagron focuses on optimizing and innovating pharmaceutical compounding to widen the therapeutic scope of prescribers worldwide.

SECTOR: Pharmaceuticals
YEAR: February 2022
DEAL SIZE: Up to $10,000,000
MANDATE TYPE: Sell-Side Advisory

Woodward Pharma Services LLC is a specialty pharmaceutical company focused on acquiring, licensing, and commercializing branded and generic prescription drugs for the U.S. market.  Woodward Pharma provides outsourced marketing, sales, and commercial services for the US pharmaceutical industry.

SECTOR: Specialty Pharma
YEAR: July 2021
DEAL SIZE: $125,000,000
MANDATE TYPE: Capital Raise

Nuvera Life Science is a consulting company dedicated to helping its clients design, build and manage a seamless patient and HCP treatment experience for rare disease and specialty therapeutics.

SECTOR: Pharma Services
YEAR: May 2021
DEAL SIZE: Up to $36 million
MANDATE TYPE: Company Sell-side

ANI Pharmaceuticals, Inc. is an integrated specialty pharmaceutical company focused on delivering value to our customers by developing, manufacturing, and marketing high quality branded and generic prescription pharmaceuticals.

SECTOR: Generic Pharma
YEAR: March 2021
DEAL SIZE: up to $249,000,000
MANDATE TYPE: Company Buy-side

ConTIPI Medical, and its associate company ConTIPI Limited provide non-surgical and disposable vaginal solutions for women with various Pelvic Floor Disorders (PFDs).

SECTOR: Medical Device
YEAR: March 2021
DEAL SIZE: Undisclosed
MANDATE TYPE: Commercialization

Apollo USA is the US subsidiary of Apollo Pharmaceuticals Inc. focused on establishing and commercializing a sterile injectable platform in the US.

SECTOR: Pharma
YEAR: December 2020
DEAL SIZE: Undisclosed
MANDATE TYPE: Company sell-side

American Injectables is a US-based sterile injectable manufacturer of parenteral drugs with a world-class facility focused on ready-to-use pre-filled syringes and vials.

SECTOR: Pharma
YEAR: September 2020
DEAL SIZE: $10 million
MANDATE TYPE: Series A Financing

International Vitamin Corporation (“IVC”) is an industry leading supplier of vitamins and nutritional/dietary supplement products.

SECTOR: Pharma
YEAR: May 2020
DEAL SIZE: Undisclosed
MANDATE TYPE: Asset Divestiture

Avista Pharma Solutions is a contract development, manufacturing, and testing organization.

SECTOR: Pharma Services/CDMO
YEAR: January 2019
DEAL SIZE: $252 million
MANDATE TYPE: Company Sell-side

Endo is a specialty pharmaceutical company that sells and manufactures branded and generic pharmaceuticals.

SECTOR: Pharma
YEAR: May 2018
DEAL SIZE: Undisclosed
MANDATE TYPE: Asset Divestiture